| P2093 | author name string | Louis Cantilena | |
| | Thomas Oliver | |
| | Jeffrey Livezey | |
| P2860 | cites work | DSM-5 | Q3064664 |
| | Discovering thiamine transporters as targets of chloroquine using a novel functional genomics strategy | Q21092414 |
| | A lesson learnt: the rise and fall of Lariam and Halfan | Q24670541 |
| | Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury | Q28296899 |
| | Adverse reaction to mefloquine associated with ethanol ingestion. | Q28368432 |
| | Addition of exogenous NAD+ prevents mefloquine-induced neuroaxonal and hair cell degeneration through reduction of caspase-3-mediated apoptosis in cochlear organotypic cultures | Q28534856 |
| | Structure, chromosomal localization, and brain expression of human Cx36 gene | Q28609846 |
| | Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons | Q33609427 |
| | Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects | Q33613720 |
| | Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine | Q33892018 |
| | MTHFR gene polymorphism and age of onset of schizophrenia and bipolar disorder. | Q33914553 |
| | The role of connexin-36 gap junctions in alcohol intoxication and consumption. | Q34634484 |
| | Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report | Q35024655 |
| | Case report: Peripheral polyneuropathy and mefloquine prophylaxis | Q35576012 |
| | Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine | Q35826033 |
| | Neuronal gap junctions play a role in the secondary neuronal death following controlled cortical impact | Q36149807 |
| | Chronic dizziness: the interface between psychiatry and neuro-otology. | Q36369745 |
| | Neuronal gap junction coupling is regulated by glutamate and plays critical role in cell death during neuronal injury. | Q36595739 |
| | Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study | Q37044939 |
| | Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression. | Q37065298 |
| | Adult malaria chemoprophylaxis prescribing patterns in the military health system from 2007-2011 | Q37089620 |
| | Mefloquine neurotoxicity: a literature review | Q37378828 |
| | Common biochemical defects linkage between post-traumatic stress disorders, mild traumatic brain injury (TBI) and penetrating TBI. | Q38305527 |
| | Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis | Q39957773 |
| | Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports | Q41642477 |
| | Paranoid psychosis related to mefloquine antimalarial prophylaxis | Q41915270 |
| | Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report | Q41929827 |
| | Suicide by skull stab wounds: a case of drug-induced psychosis | Q41934339 |
| | Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase | Q42757129 |
| | Psychotic mania associated with mefloquine in a bipolar patient | Q46643338 |
| | Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance | Q46689708 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | military | Q8473 |
| | mefloquine | Q736270 |
| P304 | page(s) | 7 | |
| P577 | publication date | 2016-12-01 | |
| P1433 | published in | Drug safety - case reports | Q27727582 |
| P1476 | title | Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine | |
| P478 | volume | 3 | |